Carestream gets FDA Clearance for Mobile X-Ray
New, more maneuverable unit joins competitors in better designed, mobile x-ray.
Carestream now has U.S. Food and Drug Administration (FDA) clearance for its DRX-Revolution Mobile X-Ray System.
Carestream put the mobile x-ray front and center at RSNA 2011, but now can take orders in the US.
The unit touts a wireless detector that can be used in other Carestream unites in a hospital to improve efficiency.
It also hosts software meant to help a radiographer quickly and accurately align the top tube with a grid for better image quality.
The top column is collapsible and a dual-drive systems enables the unit to make tight turns without strain on staff. The DRX-Revolution also offers a long tube head reach, so radiographers can conduct X-ray exams in crowded spots.
It will compete with other entries in the mobile x-ray market, such as Siemens Mobilett Mira Mobile Digital X-Ray System.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.
